Unilens Named Authorized Bausch + Lomb Boston GP Manufacturer

LARGO, Fla. and WILMINGTON, Mass., Nov. 1, 2012 /PRNewswire/ -- Unilens Vision Inc. (OTC Markets GroupOTCQB: UVIC) (TSX Venture Exchange: UVI) and Bausch + Lomb announced today that Unilens has been named an authorized Boston GP Manufacturer. The partnership will provide Unilens' GP independent practitioner accounts with the convenience to choose from a wider variety of GP lens materials that best fit the practitioner's individual patient needs.

"At Unilens, we have a longstanding commitment to supporting the growth and strength of high quality independent optometry with some of the best specialty lens technology, materials and dynamic programs available in the industry today. Our new GP manufacturing partnership with Bausch + Lomb solidifies that commitment by providing our independent practitioners with even more GP lens material options in Unilens/C-VUE lens designs, thereby contributing to more patient satisfaction and practice profitability," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc.

Unilens' bestselling GP design technology, including the all new C-Ray^® Multifocal GP and C-Vue^® GP Multifocal, will now be available in a variety of Boston materials including Boston ES^®, Boston EO^® and Boston XO^®. 

David Bland, Director-Global GP and Custom Soft Lens Business, for Boston Bausch + Lomb added, "We are excited about our partnership with Unilens Vision. Unilens will now be offering their highly successful specialty designs in our leading materials, including Boston XO^®, which features a high DK of 100 (ISO/FATT method), and is designed for GP standard and special design applications such as corneas with high oxygen demand and presbyopic designs. Also available through Unilens now will be Boston EO^® material and the Boston ES^® material, which is a good choice for emerging presbyopes, providing crisp, clear vision at near, intermediate and far distances and has a DK of 18."

All Unilens, C-Ray and C-Vue GP lens options are customizable, are sold exclusively to independent eye care professionals, feature advanced lens design technologies and offer exceptional deliverability.

About Bausch + Lomb
Bausch + Lomb is one of the best-known and most respected healthcare companies in the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 11,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.

About Unilens Vision Inc. – "The Independent Eye Care Professionals' Contact Lens Company"
Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida and its wholly owned subsidiary Unilens Vision Sciences Inc. develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue^® brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on the OTCQB under the symbol "UVIC" and on the Canadian TSX Venture Exchange under the symbol "UVI".

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

SOURCE Unilens Vision Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED